Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAVES: Pegfilgrastim in Colorectal Cancer
NCT00911170Phase 3Completed
- Sponsor
- Amgen
- Start
- Nov 2009
- Primary completion
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 17
01
Overview
A Phase 3 trial of pegfilgrastim in febrile neutropenia (FN), sponsored by Amgen. Started Nov 2009; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT00911170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911170.